Bowers v. Kelly

Summary

The United States District Court for the Northern District of California grants preliminary approval of a settlement resolving related shareholder derivative actions concerning Ginkgo Bioworks Holdings, Inc. The settlement provides for a $4.125 million payment to Ginkgo, corporate governance reforms, termination of an operating-company incubation contract, and proposed attorneys’ fees and service awards subject to further court review.

Holdings

1. Preliminary approval was warranted because the settlement appeared to result from serious, informed, arm's-length, noncollusive negotiations, had no obvious deficiencies, and fell within the range of possible approval.
2. The notice plan was adequate subject to specified amendments, including revised objection instructions, removal of the requirement that objections be separately mailed to counsel, and filing of an SEC Form 8-K within 21 days.
3. The proposed $2.75 million in attorneys' fees and expenses and the proposed $2,000 service awards did not weigh against preliminary approval, although final approval would require additional justification and information.

Questions Presented

1. Whether the proposed settlement of the shareholder derivative actions should receive preliminary approval under Federal Rule of Civil Procedure 23.1(c) and the standards incorporated from Rule 23(e).
2. Whether the proposed notice plan adequately informed Ginkgo shareholders of the settlement and their rights to object.
3. Whether the proposed attorneys' fees, costs, and service awards raised concerns requiring denial of preliminary approval.

Disposition

other